Immunoglobulin Levels in Retinal Vascular Abnormalities and Pseudoxanthoma Elasticum

Cellular Immune Response to Retinal S-Antigen and Interphotoreceptor Retinoid-Binding Protein Fragments in Eales’ Disease Patients

“…Normal immunoglobulin levels [24], raised IgG and IgA levels [25], higher IgM positivity [26], increased levels of circulating immune complexes [27] and higher levels of HLA B51, Cw1, DR1, DR4 and DR5 [28,29] have been reported in patients with Eales' disease. Elevated titers of antiretinal S-antibodies have also been detected in an Eales' patient [30].…”

Cellular Immune Response to Retinal S-Antigen and Interphotoreceptor Retinoid-Binding Protein Fragments in Eales’ Disease Patients

“…Normal immunoglobulin levels [24], raised IgG and IgA levels [25], higher IgM positivity [26], increased levels of circulating immune complexes [27] and higher levels of HLA B51, Cw1, DR1, DR4 and DR5 [28,29] have been reported in patients with Eales' disease. Elevated titers of antiretinal S-antibodies have also been detected in an Eales' patient [30].…”

Cellular Immune Response to Retinal S-Antigen and Interphotoreceptor Retinoid-Binding Protein Fragments in Eales’ Disease Patients

“…Normal immunoglobulin levels [24], raised IgG and IgA levels [25], higher IgM positivity [26], increased levels of circulating immune complexes [27] and higher levels of HLA B51, Cw1, DR1, DR4 and DR5 [28,29] have been reported in patients with Eales' disease. Elevated titers of antiretinal S-antibodies have also been detected in an Eales' patient [30].…”

Cellular Immune Response to Retinal S-Antigen and Interphotoreceptor Retinoid-Binding Protein Fragments in Eales’ Disease Patients

“…Normal immunoglobulin levels [24], raised IgG and IgA levels [25], higher IgM positivity [26], increased levels of circulating immune complexes [27] and higher levels of HLA B51, Cw1, DR1, DR4 and DR5 [28,29] have been reported in patients with Eales' disease. Elevated titers of antiretinal S-antibodies have also been detected in an Eales' patient [30].…”